G9353 HCPCS Level II code: More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with…
G9353 is the HCPCS code for “More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to…” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G9353More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)
Short description: Medrsn >1 sinus ct w 90d dx
HCPCS · United States
Medicare details
The indicators CMS publishes with G9353 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Specialist - psychiatry
- Added
- Jan 1, 2014
Where G9353 sits
- 1G codesProcedures and professional services
- 2Active code G9353More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G9353 mean?
G9353 is the HCPCS code for “More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G9353?
CMS lists G9353’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9353
All G codesG9347Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not givenG9348Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasonsG9349Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosisG9350Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosisG9351More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosisG9352More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not givenG9354One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosisG9355Elective delivery (without medical indication) by cesarean birth or induction of labor not performed (<39 weeks of gestation)G9356Elective delivery (without medical indication) by cesarean birth or induction of labor performed (<39 weeks of gestation)G9357Post-partum screenings, evaluations and education performedG9358Post-partum screenings, evaluations and education not performedG9359Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier